Semi-infectious particles contribute substantially to influenza virus within-host dynamics when infection is dominated by spatial structure
暂无分享,去创建一个
K. Koelle | R. Ke | Tin Phan | Alex P Farrell | C. Brooke
[1] L. Weinberger,et al. Identification of a therapeutic interfering particle—A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance , 2021, Cell.
[2] R. Ke,et al. Autocrine and paracrine interferon signalling as ‘ring vaccination’ and ‘contact tracing’ strategies to suppress virus infection in a host , 2021, Proceedings of the Royal Society B.
[3] R. Ke,et al. Single cell heterogeneity in influenza A virus gene expression shapes the innate antiviral response to infection , 2020, PLoS pathogens.
[4] K. Koelle,et al. Cellular co-infection can modulate the efficiency of influenza A virus production and shape the interferon response , 2019, bioRxiv.
[5] Christian Quirouette,et al. A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract , 2019, PLoS Comput. Biol..
[6] N. Jacobs,et al. Incomplete influenza A virus genomes occur frequently but are readily complemented during localized viral spread , 2019, Nature Communications.
[7] H. Dai,et al. Principles of Effective and Robust Innate Immune Response to Viral Infections: A Multiplex Network Analysis , 2019, Front. Immunol..
[8] M. Vignuzzi,et al. Defective viral genomes are key drivers of the virus–host interaction , 2019, Nature Microbiology.
[9] U. Reichl,et al. A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome , 2018, Journal of Virology.
[10] K. Koelle,et al. Causes and Consequences of Spatial Within-Host Viral Spread , 2018, Viruses.
[11] J. Bloom,et al. Single-Cell Virus Sequencing of Influenza Infections That Trigger Innate Immunity , 2019, Journal of Virology.
[12] A. Perelson,et al. Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence , 2018, Proceedings of the National Academy of Sciences.
[13] Katia Koelle,et al. Within-host infectious disease models accommodating cellular coinfection, with an application to influenza† , 2018, bioRxiv.
[14] I. Amit,et al. Dissection of Influenza Infection In Vivo by Single-Cell RNA Sequencing , 2018, Cell Systems.
[15] C. Brooke,et al. Influenza A Virus Superinfection Potential Is Regulated by Viral Genomic Heterogeneity , 2018, mBio.
[16] David J. Moquin,et al. Influenza Virus Infection Model With Density Dependence Supports Biphasic Viral Decay , 2018, bioRxiv.
[17] J. Bloom,et al. Extreme heterogeneity of influenza virus infection in single cells , 2017, bioRxiv.
[18] C. Brooke. Population Diversity and Collective Interactions during Influenza Virus Infection , 2017, Journal of Virology.
[19] D. Dou,et al. Analysis of IAV Replication and Co-infection Dynamics by a Versatile RNA Viral Genome Labeling Method. , 2017, Cell reports.
[20] Judith M. Fonville,et al. Influenza Virus Reassortment Is Enhanced by Semi-infectious Particles but Can Be Suppressed by Defective Interfering Particles , 2015, PLoS pathogens.
[21] C. Beauchemin,et al. Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility , 2015, PloS one.
[22] H. Kitano,et al. Multi-spectral fluorescent reporter influenza viruses (Color-flu) as powerful tools for in vivo studies , 2015, Nature Communications.
[23] J. Yewdell,et al. Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility , 2014, Proceedings of the National Academy of Sciences.
[24] Alan S. Perelson,et al. Impact of Different Oseltamivir Regimens on Treating Influenza A Virus Infection and Resistance Emergence: Insights from a Modelling Study , 2014, PLoS Comput. Biol..
[25] N. Dimmock,et al. Defective Interfering Influenza Virus RNAs: Time To Reevaluate Their Clinical Potential as Broad-Spectrum Antivirals? , 2014, Journal of Virology.
[26] C. Brooke,et al. Biological activities of 'noninfectious' influenza A virus particles. , 2014, Future virology.
[27] A. Osterhaus,et al. Genomewide Analysis of Reassortment and Evolution of Human Influenza A(H3N2) Viruses Circulating between 1968 and 2011 , 2013, Journal of Virology.
[28] E. Nsoesie,et al. A systematic review of studies on forecasting the dynamics of influenza outbreaks , 2013, Influenza and other respiratory viruses.
[29] D. Poole,et al. Highly Sensitive Real-Time In Vivo Imaging of an Influenza Reporter Virus Reveals Dynamics of Replication and Spread , 2013, Journal of Virology.
[30] Weixu Meng,et al. Visualizing influenza virus infection in living mice , 2013, Nature Communications.
[31] John Steel,et al. Influenza Virus Reassortment Occurs with High Frequency in the Absence of Segment Mismatch , 2013, PLoS pathogens.
[32] N. Heaton,et al. In Vivo Bioluminescent Imaging of Influenza A Virus Infection and Characterization of Novel Cross-Protective Monoclonal Antibodies , 2013, Journal of Virology.
[33] J. Yewdell,et al. Most Influenza A Virions Fail To Express at Least One Essential Viral Protein , 2013, Journal of Virology.
[34] Albert D. M. E. Osterhaus,et al. Comparison of Temporal and Spatial Dynamics of Seasonal H3N2, Pandemic H1N1 and Highly Pathogenic Avian Influenza H5N1 Virus Infections in Ferrets , 2012, PloS one.
[35] Guy Boivin,et al. The H275Y Neuraminidase Mutation of the Pandemic A/H1N1 Influenza Virus Lengthens the Eclipse Phase and Reduces Viral Output of Infected Cells, Potentially Compromising Fitness in Ferrets , 2012, Journal of Virology.
[36] A. Perelson,et al. Combination antiviral therapy for influenza: predictions from modeling of human infections. , 2012, The Journal of infectious diseases.
[37] Alan S. Perelson,et al. Modeling Within-Host Dynamics of Influenza Virus Infection Including Immune Responses , 2012, PLoS Comput. Biol..
[38] A. Perelson,et al. Influenza A virus infection kinetics: quantitative data and models , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.
[39] J. Taubenberger,et al. Influenza virus evolution, host adaptation, and pandemic formation. , 2010, Cell host & microbe.
[40] Alan S. Perelson,et al. Quantifying the Early Immune Response and Adaptive Immune Response Kinetics in Mice Infected with Influenza A Virus , 2010, Journal of Virology.
[41] Ann Cullinane,et al. Dynamics of Influenza Virus Infection and Pathology , 2010, Journal of Virology.
[42] U Reichl,et al. Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling. , 2009, Vaccine.
[43] Ruy M Ribeiro,et al. Modeling amantadine treatment of influenza A virus in vitro. , 2008, Journal of theoretical biology.
[44] Ann Cullinane,et al. Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus. , 2007, Vaccine.
[45] C. Bridges,et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. , 2007, Vaccine.
[46] R. D. de Boer,et al. Understanding the Failure of CD8+ T-Cell Vaccination against Simian/Human Immunodeficiency Virus , 2007, Journal of Virology.
[47] A. Perelson,et al. Kinetics of Influenza A Virus Infection in Humans , 2006, Journal of Virology.
[48] J. Taubenberger,et al. 1918 Influenza: the Mother of All Pandemics , 2006, Emerging infectious diseases.
[49] Bryan T Grenfell,et al. Whole-Genome Analysis of Human Influenza A Virus Reveals Multiple Persistent Lineages and Reassortment among Recent H3N2 Viruses , 2005, PLoS biology.
[50] Alan S Perelson,et al. HIV dynamics with multiple infections of target cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[51] H. Klenk,et al. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[52] R. Chanock,et al. Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. , 1980, Infection and immunity.
[53] G. K. Hirst,et al. Mechanism of influenza recombination. II. Virus aggregation and its effect on plaque formation by so-called noninfective virus. , 1973, Virology.